Erasca Touts Promising Early Data From Lead Cancer Programs
Erasca Inc (NASDAQ:ERAS) announced preliminary Phase 1/1b monotherapy data for ERAS-007 and ERAS-601 in solid tumor settings. A retrospective pooled analysis…
Alnylam Shares Detailed Patisiran Data From Rare Disease Study
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) announced positive results from the APOLLO-B Phase 3 study of patisiran for transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.
After Initial Skepticism FDA’s Adcomm Backs Amylyx’s Amyotrophic Lateral Sclerosis Hopeful
The FDA Peripheral and Central Nervous System Drugs Advisory Committee voted (7 yes and 2 no) that the…
Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug
Regeneron Pharmaceuticals Inc’s (NASDAQ:REGN) two pivotal trials evaluating aflibercept 8 mg with 12- and 16-week dosing regimens met the primary…
NexImmune Shares Jump On Immunotherapy Pact For Rare Cancers, Autoimmune Disorders
Selexis SA and NexImmune Inc (NASDAQ:NEXI) have agreed to develop cell lines targeting rare cancers and autoimmune diseases and to advance two HLAs…
Mirati’s Adagrasib Shows Promising Efficacy In KRAS Mutated Colorectal Cancer
Mirati Therapeutics Inc (NASDAQ:MRTX) announced results from the KRYSTAL-1 Phase 1/2 study of adagrasib with or without cetuximab in patients with…
Instacart Doubles Down on Technology Solutions With Local Grocery Startup Deal
Instacart is acquiring Rosie, an e-commerce platform for local and independent retailers and wholesalers. The financial terms of the deal were…
EXCLUSIVE: Nocera Takes Substantial Stake In Taiwan Based Food Processing Firm
Nocera Inc (NASDAQ: NCRA) has acquired an 80% controlling interest in Meixin Institutional Food Development Co Ltd, a Taiwan-based company, for $4.3 million.
Google’s ‘News Showcase’ Feature Almost Year Behind Schedule – What Could Be The Reason
Alphabet Inc’s (NASDAQ:GOOG) Google News Showcase program has hit a roadblock as some media outlets are unhappy with certain…